Modafinil Tablet
Product Images NDC 43353-925

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Modafinil (NDC 43353-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 200mg (43353 925)

Label for modafinil 200 mg oral tablets, containing 30 tablets per package. The label includes a warning about habit forming and mentions USP Controlled Room Temperature storage. Manufactured by Patheon Inc. in Ontario, Canada, and repackaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The product is marked RX Only.*

FDA Label Image

Chemical Structure (9f3b0bd2 72a3 411f Aeec B533373f1a97 01)

Chemical structure of modafinil, showing the molecular arrangement including two phenyl groups, a sulfinyl group, and an amide moiety.*

FDA Label Image

Warning (9f3b0bd2 72a3 411f Aeec B533373f1a97 02)

A text panel stating that modafinil tablets are a federally controlled substance (C-IV) due to potential for abuse or dependence. It advises storing tablets safely to prevent misuse, warns that selling or giving them away is illegal, and recommends informing a doctor if there is any history of substance dependence.*

FDA Label Image

Aphena Pharma Solutions (TN)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.